Drug intelligence / Profile preview

Vitaseng

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Vitaseng is a multi-ingredient dietary supplement and nutraceutical product marketed in various formulations across different regions, including by DM Pharma in India. The product is primarily used as an over-the-counter (OTC) supplement for stress adaptation, immune system support, and the treatment of vitamin deficiencies. Its formulations vary significantly by market; common ingredients include *Panax ginseng* extract (standardized for ginsenosides), vitamins such as Nicotinamide (Vitamin B3), Vitamin A, and Vitamin B6, as well as botanical components like Citrus bioflavonoids and Ginger extract. As a nutritional supplement, it is not classified as a prescription pharmaceutical and is not currently in clinical drug development pipelines.

Brand names: Vitaseng

Targets

NAD (Nicotinamide adenine dinucleotide)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Vitaseng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitaseng.

Explore the full profile